Establishment and characterization of a primary human chordoma xenograft model
- 1 April 2012
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 116 (4), 801-809
- https://doi.org/10.3171/2011.12.jns111123
Abstract
Chordomas are rare tumors arising from remnants of the notochord. Because of the challenges in achieving a complete resection, the radioresistant nature of these tumors, and the lack of effective chemotherapeutics, the median survival for patients with chordomas is approximately 6 years. Reproducible preclinical model systems that closely mimic the original patient's tumor are essential for the development and evaluation of effective therapeutics. Currently, there are only a few established chordoma cell lines and no primary xenograft model. In this study, the authors aimed to develop a primary chordoma xenograft model. The authors implanted independent tumor samples from 2 patients into athymic nude mice. The resulting xenograft line was characterized by histopathological analysis and immunohistochemical staining. The patient's tumor and serial passages of the xenograft were genomically analyzed using a 660,000 single-nucleotide polymorphism array. A serially transplantable xenograft was established from one of the 2 patient samples. Histopathological analysis and immunohistochemical staining for S100 protein, epithelial membrane antigen, and cytokeratin AE1/AE3 of the primary patient sample and the xenografts confirmed that the xenografts were identical to the original chordoma obtained from the patient. Immunohistochemical staining and western blot analysis confirmed the presence of brachyury, a recently described marker of chordomas, in the tumor from the patient and each of the xenografts. Genome-wide variation was assessed between the patient's tumor and the xenografts and was found to be more than 99.9% concordant. To the best of their knowledge, the authors have established the first primary chordoma xenograft that will provide a useful preclinical model for this disease and a platform for therapeutic development.Keywords
This publication has 24 references indexed in Scilit:
- Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional‐based studyThe Journal of Pathology, 2010
- Differential proteomic profiling of chordomas and analysis of prognostic factorsJournal of Surgical Oncology, 2010
- Characterization and Analysis of Human Chordoma Cell LinesSpine, 2010
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by CultureIn vitroCancer Research, 2009
- Identifying Mechanisms for Therapeutic Intervention in ChordomaSpine, 2008
- Chordoma and chondrosarcoma gene profile: implications for immunotherapyCancer Immunology, Immunotherapy, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- The Role of Extracellular Factors in Human Metastatic Chordoma Cell Growth In VitroSpine, 2007
- Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull baseJournal of Neurosurgery, 2006
- Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFRGenes, Chromosomes and Cancer, 2003